(Q45386214)
Statements
1 reference
Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children (English)
1 reference
Katia Abarca
1 reference
Elizabeth Jung
1 reference
Pilar Fernández
1 reference
Liang Zhao
1 reference
Brian Harris
1 reference
Edward M Connor
1 reference
Genevieve A Losonsky
1 reference
Motavizumab Study Group
1 reference
1 April 2009
1 reference
1 reference
28
1 reference
4
1 reference
267-272
1 reference
Identifiers
1 reference
1 reference